1. Home
  2. ELEV vs FPAY Comparison

ELEV vs FPAY Comparison

Compare ELEV & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • FPAY
  • Stock Information
  • Founded
  • ELEV 2019
  • FPAY 2003
  • Country
  • ELEV United States
  • FPAY United States
  • Employees
  • ELEV N/A
  • FPAY N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • ELEV Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • ELEV Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • ELEV 34.0M
  • FPAY 32.7M
  • IPO Year
  • ELEV 2021
  • FPAY N/A
  • Fundamental
  • Price
  • ELEV $0.61
  • FPAY $1.66
  • Analyst Decision
  • ELEV Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • ELEV 5
  • FPAY 2
  • Target Price
  • ELEV $7.80
  • FPAY $3.25
  • AVG Volume (30 Days)
  • ELEV 673.9K
  • FPAY 191.6K
  • Earning Date
  • ELEV 11-06-2024
  • FPAY 11-14-2024
  • Dividend Yield
  • ELEV N/A
  • FPAY N/A
  • EPS Growth
  • ELEV N/A
  • FPAY N/A
  • EPS
  • ELEV N/A
  • FPAY N/A
  • Revenue
  • ELEV N/A
  • FPAY $134,563,007.00
  • Revenue This Year
  • ELEV N/A
  • FPAY $25.65
  • Revenue Next Year
  • ELEV N/A
  • FPAY $9.38
  • P/E Ratio
  • ELEV N/A
  • FPAY N/A
  • Revenue Growth
  • ELEV N/A
  • FPAY 24.46
  • 52 Week Low
  • ELEV $0.44
  • FPAY $0.97
  • 52 Week High
  • ELEV $5.83
  • FPAY $1.95
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 51.53
  • FPAY 65.54
  • Support Level
  • ELEV $0.52
  • FPAY $1.51
  • Resistance Level
  • ELEV $0.70
  • FPAY $1.76
  • Average True Range (ATR)
  • ELEV 0.06
  • FPAY 0.12
  • MACD
  • ELEV 0.00
  • FPAY 0.05
  • Stochastic Oscillator
  • ELEV 41.81
  • FPAY 85.07

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: